Walleye Trading
INSY

Walleye Trading’s Insys Therapeutics, Inc. INSY Stock Holding History

Walleye Trading’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-474
Closed -$5K – 5737
2018
Q3 		$5K Buy
+474
New +$3.78K ﹤0.01% 5127
2017
Q4 		– Sell
-30,800
Closed -$274 – 4798
2017
Q3 		$274 Buy
+30,800
New +$318K ﹤0.01% 2987
2017
Q2 		– Sell
-39,200
Closed -$412 – 5223
2017
Q1 		$412 Sell
39,200
-11,100
-22% -$118K ﹤0.01% 2409
2016
Q4 		$463K Buy
50,300
+49,800
+9,960% +$563K ﹤0.01% 2146
2016
Q3 		$6K Buy
+500
New +$7.6K ﹤0.01% 4541
2015
Q4 		– Sell
-37
Closed -$1K – 5943
2015
Q3 		$1K Buy
+37
New +$1.36K ﹤0.01% 4862

Other funds holding INSY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Walleye Trading's INSY Position: Q4 2018 in Review

Walleye Trading sold out of Insys Therapeutics, Inc. (INSY) in Q4 2018, closing a stake of 474 shares — an estimated $5K sold.

Walleye Trading first reported a position in INSY in Q3 2015 and held it in 6 quarters. The position peaked at $463K in Q4 2016. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2018.

  • Walleye Trading reported no remaining Insys Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Walleye Trading sold 474 Insys Therapeutics, Inc. shares in Q4 2018, an estimated $5K.
  • Walleye Trading first reported a position in Insys Therapeutics, Inc. in Q3 2015 and held it in 6 quarters.
  • Walleye Trading's Insys Therapeutics, Inc. position peaked at $463K in Q4 2016.
  • 113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.